Pure Global AI
NCT06349902Recruiting

Re-link HCV in Substance-Use Telemedicine Program

Re-linking People With Diagnosed But Untreated HCV to Care in a Community-based Substance-use Telemedicine Program
trueNorth Medical CentresClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Hepatitis C
Drug/Device/Intervention
Re-Link
Study type
Observational
Intervention type
behavioral
Sponsor & location
Primary sponsor
trueNorth Medical Centres
Location
Toronto, Canada
Timeline & enrollment
Phase
N/A
Start date
Mar 12, 2024
End date
Dec 31, 2024
Enrollment
5000 participants
Primary outcome

number of patients identified as having diagnosed but untreated HCV,percentage of patients identified as having diagnosed but untreated HCV that are re-linked to HCV care

Summary

This is an observational, retrospective & prospective cohort study. The retrospective element
 of the study is a chart review to identify people with diagnosed but untreated HCV and
 re-link them to care. The observational prospective cohort element of the study will examine
 the HCV linkage to care, treatment initiation, treatment completion & cure rates of these HCV
 clients achieved through this chart review and re-linking approach.

ICD-10 classifications
Acute hepatitis CChronic viral hepatitis CViral hepatitisChronic viral hepatitisUnspecified viral hepatitis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06349902
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06349902 through Pure Global AI's free database. This phase not specified trial is sponsored by trueNorth Medical Centres and is currently Recruiting. The study focuses on Hepatitis C. Target enrollment is 5000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.